The Level of Circulating M-MDSCs as an Indicator for the Therapeutic Outcome of BNCT in End-Stage Malignant Brain Tumor Patients
This clinical study demonstrates that BNCT can reduce tumor burden, improve disease control, and prolong survival in end-stage glioma patients. Circulating M-MDSCs may serve as a predictive indicator for the treatment response of these patients following BNCT.
Authors
- George T.Y. Chen (ORCID: https://orcid.org/0000-0002-1671-4863)
- Ching‐Fang Yu (ORCID: https://orcid.org/0000-0001-8891-1690)
- Chi‐Shiun Chiang (ORCID: https://orcid.org/0000-0002-2581-4129)
- Yiwei Chen (ORCID: https://orcid.org/0000-0002-7108-6150)
- Chun‐Hsiang Chang
Institutions
- Chang Gung University (TW)
- National Tsing Hua University (TW)
- Taipei Veterans General Hospital (TW)
- Chang Gung Memorial Hospital (TW)
Publication Details
- Journal
- International Journal of Particle Therapy
- Published
- 2024-10-19
- DOI
- https://doi.org/10.1016/j.ijpt.2024.100633
- Citations
- 4
- Primary Topic
- Pharmacological Effects and Toxicity Studies
- Type
- article
- Field-Weighted Citation Impact
- 4.44
Funders
- Chang Gung University
- Chang Gung Medical Foundation
- National Tsing Hua University
- National Science and Technology Council